Meningoradiculitis associated with giant cell arteritis

Neurology

Volumn 59, Issue 11, 2002, Pages 1811-1812

  Roelcke, U ^a   Eschle, D ^a   Kappos, L ^b   Moschopulos, M ^a   Laeng, R H ^a   Buettner, U W ^a  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYTARABINE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; GIANT CELL ARTERITIS; HUMAN; MALE; MENINGORADICULITIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADICULITIS; RECURRENT DISEASE; TREATMENT OUTCOME;

EID: 0037058771     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000039924.73270.89     Document Type: Article

References (6)

1. Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsyproven giant cell (temporal) arteritis. Neurology 1988;38:352-359.
2. Gerber NL, Steinberg AD. Clinical use of immunosuppressive drugs: Part I. Drugs 1976;11:14-35.
3. Bondeson J, Asman P. Giant cell arteritis presenting with oculomotor nerve palsy. Scand J Rheumatol 1997;26:327-328.
4. Caselli RJ, Hunder GG. Neurologic complications of giant cell (temporal) arteritis. Semin Neurol 1994;14:349-353.
5. Parums DV. The arteritides. Histopathology 1994;25:1-20.
6. Nordborg E, Nordborg C, Malmvall BE, Andersson R, Bengtsson BA. Giant cell arteritis. Rheum Dis Clin North Am 1995;21:1013-1026.